Today’s world is more unpredictable than ever. From regulatory upheavals and trade tariffs to sudden shifts in consumer demand, businesses must be ready to respond swiftly and decisively. Traditional planning processes struggle to keep up with the urgent risks and opportunities that arise between meetings, triggering constant re-planning and creating room for misalignment and disorder.
Maintaining exceptional service levels to ensure quality patient care is critical to AstraZeneca, a biopharmaceutical company. But for years, its exceptional service levels came at a cost for the company in the form of elevated inventory levels and planning decisions made with limited end-to-end visibility into its supply chain, which impacted agility and growth.
Life sciences supply chains are among the most complex in the world. Every day, supply chain leaders must balance shifting demand, constrained supply, and strict regulatory requirements, all while ensuring patients get the medications they need. The margin for error is small, and disconnected, stage-by-stage planning just cannot keep up.
How do you plan for a technology that doesn't exist yet, while keeping today's production lines running? That's the challenge Bekaert faced with its titanium fiber-based porous transport layers, a breakthrough component powering industrial-scale green hydrogen production
Land O’Lakes’ supply chain leaders share how they transformed planning across three fundamentally different businesses, each with its own volatility profile and constraints. This session goes beyond technology to reveal how leadership alignment, phased execution, and deep collaboration turned complexity into resilience while achieving real, measurable results.